Therapeutics: Fusobacterium nucleatum Fap2; T cell immunoreceptor with Ig and ITIM domains (TIGIT)

Cancer

INDICATION: Cancer

In vitro studies suggest inhibiting the interaction between F nucleatum Fap2 and

Read the full 132 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE